Print Page | Contact Us | Sign In | Join ACAM
News & Press: ACAM Action Alerts

ACAM Action Alert: Chelation & TACT 2 Featured on ABC

Friday, February 3, 2017  
Posted by: Administration
Share |
CHELATION & TACT 2 FEATURED ON ABC NEWS SEGEMENT
Tune in tonight, Friday, February 3rd, to Channel 6 Action News at 11pm  (ABC network Philadelphia) and watch Dr. Allan Magaziner of the Magaziner Center for Wellness discuss an important clinical trial to assess the effectiveness of chelation therapy to reduce the risk of future heart attack, stroke or sudden death in diabetics who are over 50 and have had a prior heart attack. Dr. Magaziner is actively recruiting patients for TACT 2, a federally funded, nationwide trial. 

CAN'T WATCH IT LIVE? DON'T GET THE CHANNEL?
Visit www.6ABC.com after the original airing to view full content online.
TRIAL TO ASSESS CHELATION THERAPY (TACT 2)

When analyzing the results of the first Trial to Assess Chelation Therapy (TACT), researchers found that a subgroup of patients with diabetes who received EDTA chelation had fewer cardiovascular events than patients who did not receive EDTA chelation. This was not what researchers were expecting to find. 

Remarkably, there was a 43% reduction in mortality and a 51% reduction in overall cardiac events which included heart attack, stroke or sudden death in the diabetics who were treated with chelation therapy. This is quite a dramatic turnaround!
For more information on TACT 2: CLICK HERE

Connect With Us

380 Ice Center Lane, Suite C

Bozeman, MT 59718

1.800.532.3688

Our mission

The American College for Advancement in Medicine (ACAM) is a not-for-profit organization dedicated to educating physicians and other health care professionals on the safe and effective application of integrative medicine.